Exponent (NASDAQ:EXPO – Get Free Report) is set to release its earnings data after the market closes on Thursday, October 24th. Analysts expect Exponent to post earnings of $0.48 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.50 by $0.07. The company had revenue of $132.43 million during the quarter, compared to the consensus estimate of $130.83 million. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.50 EPS. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Trading Down 2.5 %
Shares of EXPO opened at $110.05 on Tuesday. The company’s fifty day simple moving average is $108.81 and its 200 day simple moving average is $99.40. Exponent has a 1-year low of $64.61 and a 1-year high of $115.75. The company has a market cap of $5.58 billion, a price-to-earnings ratio of 55.58 and a beta of 0.66.
Exponent Announces Dividend
Wall Street Analysts Forecast Growth
Separately, Truist Financial reissued a “buy” rating and set a $120.00 price target (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.
View Our Latest Stock Analysis on Exponent
Insider Buying and Selling at Exponent
In other news, VP John Pye sold 3,956 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now directly owns 28,422 shares of the company’s stock, valued at $2,984,310. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.10% of the company’s stock.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- How is Compound Interest Calculated?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- 3 Healthcare Dividend Stocks to Buy
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.